Patrick R. O'Neil, EVP CLO & General Counsel at IONIS PHARMACEUTICALS INC (IONS), sold 50,600 shares at $64.68 ($3.3M) on 2025-09-30, disclosed to the SEC on 2025-10-01.
Scheduled sale ($3.3M) by EVP CLO & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.54 | 10,473 | $676K | 20.7% |
| 2 | $64.54 | 10,473 | $676K | 20.7% |
| 3 | $64.68 | 14,827 | $959K | 29.3% |
| 4 | $64.68 | 14,827 | $959K | 29.3% |
| Total | $64.62 avg | 50,600 | $3.3M | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $516K | — | Filing → |
| IONS | SELL | 2026-01-20 | $697K | — | Filing → |
| IONS | SELL | 2025-10-08 | $1.2M | — | Filing → |